Precision Oncology: Translating Discovery to the Clinic | EK45
Sessions
Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia
Speaker(s):
- Ekaterina Akimova, MSc, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR)
An unveiled Cell-Death Mechanism Exclusive to Human Cancer Cells
Preview Available
An unveiled Cell-Death Mechanism Exclusive to Human Cancer Cells
Speaker(s):
- Malka Armon, PhD, Tel-Aviv University
The development of a personalized CAM Avatar model to predict chemotherapeutic drug sensitivity/resistance of malignant glial tumors.
Preview Available
The development of a personalized CAM Avatar model to predict chemotherapeutic drug sensitivity/resistance of malignant glial tumors.
Speaker(s):
- Martine Charbonneau, MSc, Sherbrooke University
Precision Pathology Through Emerging Technologies: Evaluating Tumor Burden in Melanoma Sentinel Lymph Nodes by Precise Digital Cell Counting
Preview Available
Precision Pathology Through Emerging Technologies: Evaluating Tumor Burden in Melanoma Sentinel Lymph Nodes by Precise Digital Cell Counting
Speaker(s):
- Alessio Giubellino, MD, PhD, University of Minnesota Medical School
Human Papilloma Virus Integration Strictly Correlates with Global Genome Instability in Head and Neck Cancer
Preview Available
Human Papilloma Virus Integration Strictly Correlates with Global Genome Instability in Head and Neck Cancer
Speaker(s):
- David Goldrich, MD, Penn State Milton S. Hershey Medical Center
The Chicken Chorioallantoic Membrane Tumor Assay as a Relevant In Vivo Model to Study the Impact of Hypoxia on Tumor Progression and Metastasis
Preview Available
The Chicken Chorioallantoic Membrane Tumor Assay as a Relevant In Vivo Model to Study the Impact of Hypoxia on Tumor Progression and Metastasis
Speaker(s):
- Kelly Harper, PhD, Université de Sherbrooke
Clinical Feasibility and Treatment Outcomes With Unselected Autologous Tumor Infiltrating Lymphocyte Therapy in Patients With Advanced Cutaneous Melanoma
Preview Available
Clinical Feasibility and Treatment Outcomes With Unselected Autologous Tumor Infiltrating Lymphocyte Therapy in Patients With Advanced Cutaneous Melanoma
Speaker(s):
- Robert Hawkins, PhD, Instil Bio, Inc.
Synthetic lethality-mediated precision oncology via the tumor transcriptome
Speaker(s):
- Joo S. Lee, PhD, National Cancer Institute
Application of network-based systems pharmacology in precision medicine for T-cell acute lymphoblastic leukemia
Preview Available
Application of network-based systems pharmacology in precision medicine for T-cell acute lymphoblastic leukemia
Speaker(s):
- Jingjing Liu, PhD, St Jude Children's Research Hospital
Ex vivo expansion and drug sensitivity profiling of circulating tumor cells in patients with soft tissue sarcoma
Preview Available
Ex vivo expansion and drug sensitivity profiling of circulating tumor cells in patients with soft tissue sarcoma
Speaker(s):
- Long-Sheng Lu, MD, PhD, Taipei Medical University